Eliem Therapeutics, Inc. (ELYM) Social Stream
ELIEM THERAPEUTICS INC (ELYM) Price Targets From Analysts
Use the tables below to see what analysts covering ELIEM THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-21 | 3 | $35 | $32 | $33.333 | $2.73 | 1120.99% |
| 2022-05-16 | 3 | $35 | $13 | $26.666 | $2.73 | 876.78% |
| 2022-07-21 | 3 | $35 | $9 | $25.333 | $2.73 | 827.95% |
| 2022-08-02 | 3 | $32 | $8 | $16.333 | $2.73 | 498.28% |
| 2022-08-16 | 3 | $32 | $4 | $14.666 | $2.73 | 437.22% |
| 2023-01-23 | 4 | $8 | $4 | $6 | $2.73 | 119.78% |
| 2023-03-08 | 1 | $6 | $6 | $6 | $2.73 | 119.78% |
| 2023-04-20 | 4 | $8 | $4 | $6 | $2.73 | 119.78% |
| 2023-05-12 | 3 | $8 | $4 | $6 | $2.73 | 119.78% |
| 2023-05-16 | 3 | $6 | $4 | $5 | $2.73 | 83.15% |
The Trend in the Analyst Price Target
ELYM's average price target has moved down $28.33 over the prior 20 months.
ELYM reports an average of 73.43% for its upside potential over the past 113 days.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-23 | 4 | 8 | 4 | 6 | 3.995 | 50.19% |
| 2023-03-08 | 4 | 8 | 4 | 6 | 3.640 | 64.84% |
| 2023-03-08 | 1 | 8 | 4 | 6 | 3.640 | 64.84% |
| 2023-03-08 | 4 | 6 | 6 | 6 | 3.640 | 64.84% |
| 2023-05-12 | 3 | 8 | 4 | 6 | 3.200 | 87.5% |
ELYM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 2 | 0 | 1 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
ELYM's average broker recommendation rating worsened by 0.42 over the prior 19 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ELYM as an investment opportunity.
- ELYM has a greater number of analysts covering the stock than 65.1% of all US stocks.
- In terms of how ELIEM THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 806.96% of that group.
- In the context of all US stocks, ELIEM THERAPEUTICS INC's variance in analysts' estimates is lower than -467.87% of them.
- ELIEM THERAPEUTICS INC's average analyst price target is higher than 346.31% of stocks in the small market cap category.
In the Pharmaceutical Products industry, TYRA, THRX, and PYXS are the three stocks most similar to ELIEM THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is ELYM a Buy, Hold or Sell? See the POWR Ratings now!